MedAlliance Announces Enrollment of First Patient in Erectile Dysfunction Feasibility Study with Sirolimus Drug-Eluting Balloon
- Written by PR Newswire Asia - Daily Bulletin Au RSS
NYON, Switzerland, Aug. 19, 2021 /PRNewswire/ -- MedAlliance has announced enrollment of the first patient in an erectile dysfunction (ED) feasibility study with its sirolimus drug-eluting balloon [DEB]. This occurred at the University of Rome Tor Vergata, Italy, under the direction of the study's Principal Investigator, Professor of...